Valuation: Novartis AG

Market Cap 297B 259B 241B 221B 417B 28,389B 424B 2,836B 1,113B 14,133B 1,117B 1,092B 47,392B P/E 2026 *
22.2x
P/E 2027 * 19x
Enterprise Value 331B 287B 267B 246B 464B 31,550B 471B 3,152B 1,237B 15,707B 1,241B 1,214B 52,669B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 5.32x
Free-Float
91.66%
Yield 2026 *
2.8%
Yield 2027 * 2.92%
1 day-0.14%
1 week-0.24%
1 month+0.02%
3 months+9.23%
6 months+10.45%
Current year+15.51%
1 week 125.9
Extreme 125.9
131.5
1 month 121.06
Extreme 121.06
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 91.56
Extreme 91.56
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Chief Tech/Sci/R&D Officer 64 2022-05-15
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Date Insider Type Main position Quantity % Market Cap.
2/17/26 Sell 30,743 0.0015%
2/10/26 Sell 7,500 0.0004%
2/9/26 Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-0.14%-0.24%+34.41%+39.01% 297B
-0.53%-3.95%+55.23%+152.74% 1,024B
+0.21%-2.68%+55.61%+53.02% 618B
-2.51%-3.25%+32.76%+67.76% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.69%-0.30%+11.55%+12.93% 264B
-7.37%-4.40%-2.54%-43.87% 209B
-0.64%+2.43%+30.52%+64.49% 208B
-0.82%+0.70%+15.96%+71.01% 162B
+0.40%+1.92%+7.39%-30.64% 143B
Average -1.20%-1.12%+27.84%+41.71% 371.63B
Weighted average by Cap. -0.94%-1.87%+38.02%+68.98%

Financials

2026 *2027 *
Net sales 57.58B 50.06B 46.59B 42.78B 80.78B 5,497B 82.03B 549B 216B 2,737B 216B 212B 9,176B 61.12B 53.13B 49.46B 45.41B 85.75B 5,835B 87.08B 583B 229B 2,905B 230B 225B 9,740B
Net income 13.78B 11.98B 11.15B 10.24B 19.33B 1,315B 19.63B 131B 51.58B 655B 51.75B 50.62B 2,196B 15.36B 13.35B 12.43B 11.41B 21.54B 1,466B 21.88B 146B 57.49B 730B 57.68B 56.41B 2,447B
Net Debt 33.11B 28.79B 26.79B 24.6B 46.45B 3,161B 47.17B 316B 124B 1,574B 124B 122B 5,277B 27.82B 24.18B 22.51B 20.66B 39.02B 2,655B 39.63B 265B 104B 1,322B 104B 102B 4,433B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26-07-31 CHF 126.60 -0.14% 2,230,428
26-07-30 CHF 126.78 -2.28% 2,232,247
26-07-29 CHF 129.74 -0.51% 2,331,609
26-07-28 CHF 130.40 +1.46% 2,558,238
26-07-27 CHF 128.52 +1.28% 2,435,055
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
156.46USD
Average target price
153.99USD
Spread / Average Target
-1.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock